Skip to main content
Live · TradingView
Back to the NewsWire

Marketscreener

Published September 14, 2026

Definium's LSD -based drug lowers anxiety in new late-stage trial, shares soar

Read the full story at Marketscreener

Definium Therapeutics said its LSD -based treatment reduced symptoms of generalized anxiety disorder in a second successful late-stage study,.

Surfaced by 2 Google Alerts

  • LSD
  • Psychedelic biotech